Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2008-05-06
2008-05-06
Saoud, Christine J. (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C536S023500, C435S069100, C435S320100, C435S325000
Reexamination Certificate
active
10980560
ABSTRACT:
Disclosed herein are non-endogenous, constitutively activated forms of the human 5-HT2Aand human 5-HT2Creceptors and uses of such receptors to screen candidate compounds. Further disclosed herein are candidate compounds identified by the screening method which act at the 5HT2Areceptors. Yet further disclosed is a new class of compounds which act at the 5HT2Areceptors.
REFERENCES:
patent: 4985352 (1991-01-01), Julius et al.
patent: 5661024 (1997-08-01), Kao et al.
patent: 5885785 (1999-03-01), Kao et al.
patent: 6358698 (2002-03-01), Weiner et al.
patent: 6383762 (2002-05-01), Kao et al.
patent: 2002/0098548 (2002-07-01), Kao et al.
patent: 2135253 (1996-05-01), None
patent: WO 96/23783 (1996-08-01), None
Cook et al, GenEmbl database, accession No. S71229, Sep. 23, 1994.
Chen et al, PIR 80 database, accession No. A43956, Dec. 31, 1993.
Schmidt, C., “The Role of 5-HT2A Receptors in Antipsychotic Activity,” Life Sciences. (1995) 56(25): 2209-2222.
Ikeguchi, K. and Kuroda, A., “Mianserin Treatment of Patients With Pyschosis Induced by Antiparkinsonian Drugs” Eur Arch Psych Clin Neurosci. (1995) 244: 320-324.
Mizuki, Y., et al., “Effects of Mianserin on Negative Symptoms in Schizophrenia” Int. Clinical Psychopharmacology, (1990) 5: 83-95.
Wikstrom, H., et al. “Synthesis and Pharmacological Testingof 1,2,3,4,10,14b-Hexahydro-6-methoxy . . . ” J. Med. Chem. (2002) 45: 3280-3285.
Newton, R. A. and Elliott, J.M., “Mianserin-Induced Down-Regulation of Human 5-Hydroxytryptamine2A and 5-Hydro . . . ” Journal of Neurochemistry. (1997) 69:1031-1038.
Grotewiel et al., “Receptors Exhibit Constitutive Activity that is Blocked by Inverse Agonists,” Faseb J. (May 21-25, 1994) 8(7): Abstract 353.
Van Zwieten, PA. “Receptors Involved in the Regulation of Vascular Tone,” Arzneimittelforschung. (1985) 35(12A): 1904-9.
Affolter, H. “CA2+ as Messenger of 5HT2-Receptor Stimulation in Human Blood Platelets,” Naunyn Schmiedebergs Arch Pharmacol. (1984) 325(4): 337-42.
Ieni, J. and Meyerson, L., “The 5-HT1A Receptor Probe [3H] 8-OH-DPAT labels . . . ” Life Sciences. (1988) 42: 311-320.
Julius, D., et al., “The 5HT2 Receptor Defines a Family of Structurally Distinct but Functionally Conserved Serotonin Receptors”, Proc. Natl., Acad. Sci. USA (1990) 87:928-932.
Barluenga, J. et al., “A New and Specific Method for the Monomethylation of Primary Amines,”J. Chem. Soc. Chem. Commun., 1984, 20, 1334-1335.
Batey, R.A. et al., “An Efficient New Protocol for the Formation of Unsymmetrical Tri- and Tetrasubstituted Ureas,”Tetra. Lett., 1998, 39, 6267-6270.
Bernatowicz, M. et al., “A Comparsion of Acid Labile Linkage Agents for the Synthesis of Peptide C-Terminal Amides,”Tetra. Lett., 1989, 30(35), 4645-4648.
Carter, H.E. et al., “Carbobenzoxy Chloride and Derivatives,”Org. Syn. Coll., 1955, vol. 3, 167-169.
Casey, C. et al., “Constitutively Active Mutant 5HT2ASerotonin Receptors: Inverse Agonist Activity of Classical 5HT2AAntogonists,”Society for Neuroscience Abstracts, 1996, 22(3), Abstract No. 699.10.
Gutsche, C.D. et al., “2-Phenylcycloheptanone,”Org. Syn. Coll., 1963, vol. 4, 780-783.
Herrick-Davis, K. et al., “Activating Mutations of the Serotonin 5-HT2CReceptor,”J. Neurochem., 1997, 69(3), 1138-1144.
Herrick-Davis, K. et al., “Constitutively Active 5HT2C Serotonin Receptor Created by Site-Directed Mutagenesis,”Society for Neuroscience Abstracts, 1996, 22(3), Abstract No. 699.18.
Konig, W. et al., “A New Method for Synthesis of Peptides: Activation of the Carboxyl Group with Dicyclohexylcarbodiimide using 1-Hydroxybenzotriazoles as Additives,”Chem. Ber., 1970, 103, 788-798 (English abstract included).
Marchini, P. et al., “Sodium Borohydride-Carboxylic Acid Systems. Useful Reagents for the Alkylation of Amines,”J. Org. Chem., 1975, 40(23), 3453-3456.
Sahgal, A. (ed.), “Practical behavioral neuroscience: problems, pitfalls and suggestions,” inBehavioral Neuroscience: A Practical Approach, IRL Press, New York, 1993, vol. 1, 1-8.
Sheehan, J.C. et al., “1-Ethyl-3-(3-Dimethylamiono)Propylcarbodiimide Hydrochloride and Methiodide,”Org. Syn. Coll., 1973, vol. 5, 555-558.
Soresnon et al., “Characterization of the 5-HT2Receptor Antagonist MDL 100907 as a Putative Atypical Antipsychotic: Behavioral, Electrophysiological and Neurochemical Studies,”J. Pharacol. Exp. Ther., 1993, 266(2), 684-691.
White, E., “Deamination of Amines. 2-Phenylethyl Benzoate Via the Nitrosoamide Decomposition,”Org. Syn. Coll., 1973, vol. 5, 336-339.
Barluenga. J. et al., “A New and Specific Method for the Monomethylation of Primary Amines,”J. Chem. Soc. Chem. Commun., 1984, 20, 1334-1335.
Batey, R.A. et al., “An Efficient New Protocol for the Formation of Unsymmetrical Tri-and Tetrasubstituted Ureas,”Tetra. Lett., 1988, 39, 6267-6270.
Bernatowicz, M. et al., “A Comparison of Acid Labile Linkage Agents for the Synthesis of Peptide C-Terminal Amides,”Tetra. Lett., 1989, 30(35), 4645-4648.
Carter, H.E. et al., “Carbobenzoxy Chloride and Derivatives,”Org. Syn. Coll., 1955, vol. 3, 167-169.
Casey, C. et al., “Constitutively Active Mutant 5HT2ASerotonin Receptors: Inverse Agonist Activity of Classical 5HT2AAntagonists,”Society for Neuroscience Abstracts, 1996, 22(3), Abstract No. 699.10.
Gutsche, C.D. et al., “2-Phenylcycloheptanone,”Org. Syn. Coll., 1963, vol. 4, 780-783.
Herrick-Davis, K. et l., “Activating Mutations of the Serotonin 5-HT2CReceptor,”J. Neurochem., 1997, 69(3), 1138-1144.
Herrick-Davis, K. et l., “Constitutively Active 5HT2C Serotonin Receptor Created by Site-Directed Mutagenesis,”Society for Neuroscience Abstracts, 1996, 22(3), Abstract No. 699.18.
Konig, W. et al., “A New Method for Synthesis of Peptides: Activation of the Carboxyl Group with Dicyclohexylcarbodiimide Using 1-Hydroxybenzotrialzoles as Additives,”Chem. Ber., 1970, 103, 788-798 (English Abstract included).
Marchini, P. et al., “Sodium Borohydride-Carboxylic Acid Systems. Useful Reagents for the Alkylation of Amines,”J. Org. Chem., 1975, 40(23), 3453-3456.
Sahgal, A. (ed.), “Practical behavioral neuroscience: problems, pitfalls and suggestions,” inBehavioral Neuroscience: A Practical Approach, IRL Press, New York, 1993, vol. 1, 1-8.
Sheehan, J.C. et al., “1-Ethyl-3-(3-Dimethylamiono)Proplycarbodiimide Hydrochloride and Methiodide,”Org. Syn. Coll., 1973, vol. 5, 555-558.
Soresnon et al., “Characterization of the 5-HT2Receptor Antagonist MDL 100907 as Putative Atypical Antipsychotic: Behavioral, Electrophysiological and Neurochemical Studies,”J. Pharacol. Exp. Ther., 1993, 266(2), 684-691.
White, E., “Deamination of Amines. 2-Phenylethyl Benzoate Via the Nitrosoamide Decomposition,”Org. Syn. Coll., 1973, vol. 5, 336-339.
Behan Dominic P.
Chalmers Derek T.
Liaw Chen W.
Russo Joseph F.
Thomsen William J.
Arena Pharmaceuticals Inc.
Basi Nirmal S.
Bozicevic Field & Francis LLP
Francis Carol L.
Saoud Christine J.
LandOfFree
Non-endogenous, constitutively activated human serotonin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-endogenous, constitutively activated human serotonin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-endogenous, constitutively activated human serotonin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3955200